About
About
Roadmap
Trends
DOI Service
Subjects
Journals
Publishers
All
University
Government
TRH
Association
Foundation
Trade Association
Company
Person
Union
Researchers
Journal Wizard
Help
English
Turkish
English
Admin Panel
User Panel
My Journals
My Research
My Followers
Profile
Logout
Login
Olcay Kandemir
Publication
2
Review
0
CrossRef Cited
1
2
Publication
0
Review
1
CrossRef Cited
Follow
Following
Edit My Profile
Followers
Following
Summary
Publications
Peer Review
Cited
Institution
Publications
Comparison of the expression of GATA-3 protein from the transcription factor family and pathological prognostic parameters in invasive ductal carcinomas of the breast
Authors:
Leymune Parlak
,
Olcay Kandemir
Published: 2022 ,
Turkish Journal of Internal Medicine
DOI: 10.46310/tjim.1090713
FAVORITE
0
TOTAL DOWNLOAD COUNT
255
0
FAVORITE
255
TOTAL DOWNLOAD COUNT
The Effect Of Beclin 1, P53 Mutation, Ki-67 Proliferation İndex, Tumor Necrosis and Microvascular İnvasion On Prognosis İn Renal Cell Carcinomas and Their Relationship With Known Prognostic Parameters
Authors:
İlke Evrim Seçinti
,
Egemen Akıncıoğlu
,
Olcay Kandemir
Published: 2021 ,
Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
DOI: 10.17517/ksutfd.794679
FAVORITE
0
TOTAL DOWNLOAD COUNT
333
0
FAVORITE
333
TOTAL DOWNLOAD COUNT
Articles published in
Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
Turkish Journal of Internal Medicine
User doesn't have any peer review duties on DergiPark.
Publications
The Effect Of Beclin 1, P53 Mutation, Ki-67 Proliferation İndex, Tumor Necrosis and Microvascular İnvasion On Prognosis İn Renal Cell Carcinomas and Their Relationship With Known Prognostic Parameters
Authors:
İlke Evrim Seçinti
,
Egemen Akıncıoğlu
,
Olcay Kandemir
Published: 2021 ,
Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
DOI: 10.17517/ksutfd.794679
CITED
1
FAVORITE
0
TOTAL DOWNLOAD COUNT
333
1
CITED
0
FAVORITE
333
TOTAL DOWNLOAD COUNT
Interactive Guide Tool
If you want to see the panel introduction, you can click Start Tour.
Start Tour